People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Asterias Biotherapeutics, Inc. | — | Biotechnology | Series A | $16.6M | $144.6M | 2015 |
Andrew T. Arno at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew T. Arno on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alfred D Kingsley | 1 | 6 |
| Michael D West | 1 | 6 |
| Robert W Peabody | 1 | 3 |
| Pedro Lichtinger | 1 | 2 |
| Richard T. Lebuhn | 1 | 2 |
| JUDITH W SEGALL | 1 | 1 |
| Jane S Lebkowski | 1 | 1 |
| Katharine S Spink | 1 | 1 |
| Judith T. Segall | 1 | 1 |
| Natale T. Ricciardi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.